Keywords: Merck & Co, Sun Pharma, JV, Branded generics, Emerging markets, S. auareaus vaccine, Intercell

Merck & Co joins forces with Sun Pharma for generics in emerging markets; halts S. aureus vaccine study

Article | 12 April 2011

Print This

US drugs giant Merck & Co (NYSE: MRK) and India’s Sun Pharmaceutical Industries (SUNPHARMA, BSE: 524715) are to create a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in